Orca1

FDA inspection

Germiphene Corporation: FDA inspection ending Oct 15, 2004

FDA inspection 355260 · Brantford

Key facts

Inspection ID 355260
Firm Germiphene Corporation
FEI number 3000166001
Address 1379 Colborne St E, Ss 13
City Brantford
Fiscal year 2005
Inspection end date Oct 15, 2004
Project area Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Other inspections at this establishment

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections